What Human Med AG does

Human Med AG is a privately held German medical device manufacturer headquartered in Schwerin, founded in 2004 and operating for over 20 years. The company designs, develops, and manufactures the complete body-jet® product family and accessory systems entirely at its Schwerin facility, holding worldwide patents on its core water-jet assisted liposuction (WAL) technology. Its product portfolio comprises capital equipment including the body-jet®, body-jet® neo, body-jet® evo, and body-jet® eco devices for selective fat tissue removal using a focused water jet, alongside the FillerCollector® and LipoCollector® for autologous fat harvesting, and the Q-graft® system for stromal vascular fraction (SVF) cell concentration in regenerative medicine applications. The branded AquaShape® method combines WAL-based fat extraction with high-viability fat transfer, with clinical evidence supporting up to 90% fat cell viability and 87% retention rates in autologous procedures.

The company generates revenue through hardware sales of capital equipment and accessories to plastic surgeons, hospitals, and aesthetic clinics. Pricing is not publicly disclosed; customers contact the company directly for quotes, consistent with a premium medical device positioning. Distribution operates through a hybrid model combining exclusive regional distributors (PMS in UAE/Middle East, PMC Medical in southern Germany, Novantis Médical in France, Premium Equity Partners in Benelux and UK, ViệnThẩmMỹSIAM in Southeast Asia, and CAREstream America in North America) with direct sales to physicians and clinics. The customer base spans two primary use-case segments: aesthetic plastic surgery (breast augmentation, gluteal augmentation, body contouring, facial rejuvenation, facelifts) and reconstructive/regenerative medicine (lipoedema treatment, breast reconstruction, wound healing).

Human Med AG maintains ISO 13485 and MDSAP certifications, operates the WAL Academy training platform for physician and distributor education, and engages in active R&D including the €2.4M EFRE-funded WAVE-Jet consortium project with the University of Rostock targeting lipoedema solutions. The company is founder- and management-owned with no disclosed venture capital, private equity, or institutional investor backing, and operates as an independent entity under German corporate law (Aktiengesellschaft). Marketing relies on medical conference presence, peer-reviewed publications, webinars, and the DocFinder physician directory rather than consumer-facing channels, reflecting a pure B2B medical device GTM motion.

Name

Human Med AG

Legal name

Human Med AG

Website

https://humanmed.com

Company type

Private

Founded year

2004

Operating status

Operating

Short description

Human Med AG is a German medical device manufacturer that designs, develops, and produces patented water-jet assisted liposuction (WAL) systems, selling the body-jet® family and accessory collectors to plastic surgeons, hospitals, and aesthetic clinics worldwide through distributors and direct sales.

Ownership category

akta.pro rank

Product category

Aesthetic Surgery Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

akta.pro secondary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Water-jet assisted liposuction
• Aesthetic medical devices
• Autologous fat transfer
• Plastic surgery equipment
• Liposuction technology

Headquarters

HQ city

Schwerin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales (Capital Equipment): Human Med AG manufactures and sells medical capital equipment (body-jet® device family and accessory collectors) to plastic surgeons, hospitals, and clinics globally through direct sales and distributor networks. Revenue is generated from device sales, with after-sales service and support. The company operates in the premium medical device segment with products developed and manufactured entirely in Germany.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Human Med AG manufactures and sells the body-jet® device family (body-jet®, body-jet® neo, body-jet® evo, body-jet® eco) for water-jet assisted liposuction (WAL), along with the FillerCollector®, LipoCollector®, and Q-graft® systems for harvesting, collecting, and concentrating adipose tissue. The products are used by plastic surgeons, hospitals, and aesthetic clinics for aesthetic body contouring, breast augmentation, facial rejuvenation, lipoedema treatment, and regenerative medicine procedures. All devices are developed and manufactured in Schwerin, Germany.

Product overview

Human Med AG offers a portfolio of medical devices for water-jet assisted liposuction (WAL) using the AquaShape® method. The core product line includes the body-jet® family (body-jet®, body-jet® evo, body-jet® eco, body-jet® neo) which are medical devices for gentle fat removal using water jet technology. Supporting the body-jet® devices are collector systems: FillerCollector® and LipoCollector® for harvesting fat tissue, and Q-graft® for SVF cell extraction and concentration. All products are developed and manufactured in Schwerin, Germany, and are used for aesthetic plastic surgery, reconstructive procedures, and regenerative medicine applications including breast augmentation, body contouring, and lipedema treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• body-jet® Flagship water-jet assisted liposuction (WAL) device for gentle and selective fat cell removal using the power of water jet streams. Used by plastic surgeons and aesthetic clinics for body contouring and fat harvesting procedures.
• body-jet® neo Next-generation water-jet assisted liposuction device featuring advanced technology for enhanced precision in fat removal procedures. The latest addition to the body-jet® family, prominently featured as a new product on the company's homepage.
• body-jet® evo Evolution of the body-jet® device with improved features for water-jet assisted liposuction procedures.
• body-jet® eco Compact version of the body-jet® device for precise extraction of smaller fat tissue quantities, designed for targeted contouring procedures.
• FillerCollector® Device for harvesting small to medium volumes of adipose tissue for autologous fat transfer procedures. Used by plastic surgeons performing fat grafting, breast augmentation, and facial rejuvenation.
• LipoCollector® Fat collection system designed for harvesting larger volumes of adipose tissue during liposuction procedures. Used alongside the body-jet® device family for high-volume fat harvesting.
• Q-graft® Stromal vascular fraction (SVF) cell harvesting and concentration system for regenerative medicine applications. Used immediately after liposuction in the sterile operating room environment to isolate and concentrate SVF cells for therapeutic use.

Quantifiable outcome

• Up to 90% fat cell viability with WAL vs. lower viability with conventional methods
• +4 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered minor, major and core.

• LIO Lipedema ItaliaminorGTM or Marketing Partner · 1 January 2023Italian patient advocacy organization dedicated to the recognition of lipoedema as a chronic and disabling condition. Human Med AG cooperates with LIO Italia to support activities that increase awareness and acceptance of lipoedema and its surgical treatment options.
• Premium Equity Partners (Pieter van Halem)majorChannel Partner/ Reseller/ Distributor · 1 August 2022Distribution partner covering Benelux and UK markets. The partnership with Human Med AG was expanded from existing successful collaboration in Czech Republic and Slovakia (where LIPOELASTIC operates) to additional European territories.
• LIPOELASTICminorGTM or Marketing Partner · 1 August 2022Medical compression garment manufacturer with established presence in Czech Republic and Slovakia. Human Med AG and LIPOELASTIC are expanding their European partnership to include Benelux and UK markets, building on successful collaboration in Central Europe.
• Department of Cell Biology, Rostock University Medical CentercoreStrategic or Co-development PartnerResearch partner in the WAVE-Jet consortium project focused on developing solutions for the surgical treatment of lipoedema. The collaboration interlinks industrial medical technology with university-level cell biology research, incorporating the latest advances in technology and research into Human Med AG's product development.
• Department of Microfluidics, University of RostockcoreStrategic or Co-development PartnerResearch partner in the WAVE-Jet consortium project. The collaboration with the university's microfluidics department enables advanced engineering research integrated directly into Human Med AG's planned WAL technology developments.
• Premium Medical Supplies (PMS)majorChannel Partner/ Reseller/ DistributorExclusive distributor for Human Med AG products in the UAE and Middle East region. Supports WAL training and workshop programs at facilities such as Emirates Hospital Dubai and Valiant Clinic Dubai. Provides ongoing commercial and technical support for WAL adoption in the region.
• PMC Medical (Günther Waetzold)majorChannel Partner/ Reseller/ DistributorRegional distribution partner for southern Germany. Represents Human Med AG at key industry events including ESPRAS Munich 2023 and IBSD Düsseldorf. Supports live surgery demonstrations and symposium presentations at European conferences.
• Novantis MédicalmajorChannel Partner/ Reseller/ DistributorDistribution partner representing Human Med AG at SOFCPRE 2022 in Paris, France. Supports Human Med's presence and WAL technology promotion in the French market.
• ViệnThẩmMỹSIAM ThailandmajorChannel Partner/ Reseller/ DistributorLeading cosmetic surgery center and key distribution partner driving WAL adoption in Southeast Asia. Performed over 1,000 WAL procedures with body-jet® and received Human Med's Certificate of Appreciation for driving regional market growth. CEO Richard Son leads the medical team expanding WAL in Thailand and Vietnam.
• CAREstream AmericaminorChannel Partner/ Reseller/ DistributorDistribution partner providing a webinar archive for Human Med's educational content. Hosted CAREstream America webinars featuring Dr. Kai Kaye on water-jet assisted facelifting as part of the Lunch n' Learn series. Webinar archive available at carestreamamerica.com.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• MicroAire Surgical Instruments: MicroAire manufactures power-assisted liposuction (PAL) devices and related surgical instruments for plastic and orthopedic surgery. It competes directly with Human Med in the liposuction device category, targeting plastic surgeons with an alternative modality.
• InMode Ltd. InMode develops and markets minimally invasive and non-invasive aesthetic medical devices including BodyTite (RF-assisted liposuction) and Evolve (body contouring). It is a direct peer competing for the same plastic surgeon customer base with adjacent body contouring and fat reduction technologies.
• Solta Medical: Solta Medical (owned by Bausch Health) markets Liposonix and VASER (ultrasound-assisted liposuction) systems. It directly competes with Human Med's body-jet® in the body contouring and liposuction device category, serving the same plastic surgeon and aesthetic clinic customers.

Broad incumbents

• Cutera: Cutera markets aesthetic and dermatology medical devices including body sculpting platforms (truSculpt). It targets an overlapping customer base of plastic surgeons, dermatologists, and aesthetic clinics with comparable treatment modalities.
• Alma Lasers: Alma Lasers (part of Sisram Medical) is a broad incumbent in aesthetic medical devices including lasers, RF, ultrasound, and body contouring platforms. It serves the same plastic surgeon customer base as Human Med with a wider device portfolio spanning multiple modalities.
• Cynosure: Cynosure (owned by Healtium Investment Holdings) markets a broad portfolio of aesthetic devices including body contouring systems. It targets the same plastic surgeon and medical spa customers as Human Med with overlapping but broader modality coverage.
• BTL Aesthetics: BTL Aesthetics manufactures non-invasive body contouring and aesthetic devices (EMSCULPT, EMSCULPT NEO). It targets plastic surgeons and aesthetic clinics with body shaping devices that overlap with Human Med's body contouring market, though through different technology.
• AbbVie (Allergan Aesthetics): Allergan Aesthetics, an AbbVie company, owns the CoolSculpting (cryolipolysis) brand and other body contouring franchises. It competes with Human Med's body-jet® in the body contouring category but offers a non-invasive alternative with much greater commercial scale.

Emerging players

• Tulip Medical Products: Tulip Medical Products manufactures disposable and reusable instruments for fat grafting and autologous fat transfer, including the Coleman-style liposuction cannula system. It competes with Human Med's collector systems (FillerCollector®, LipoCollector®) in the fat transfer workflow serving plastic surgeons.
• Apyx Medical: Apyx Medical markets the Renuvion system for subdermal skin coagulation and body contouring procedures. It operates in an adjacent aesthetic device category targeting plastic surgeons, overlapping with Human Med's body-jet® in body contouring procedure workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/humanmed
• LinkedInlinkedin.com/company/humanmed
• Instagraminstagram.com/humanmed

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Human Med AG